July 2021

Largest study of its kind highlights the link between COVID-19 & heart attack, stroke | New data from Heart Rhythm 2021 ()
July in Review: Cardiologists worth at least $5M | TAVR vs. SAVR after 8 years | Reducing burnout ()
Week in Review: The top US hospitals for cardiology | Accurate AI | Heart Rhythm 2021 & TVT 2021 ()
Hearts from illicit drug users safe to transplant | TEER & cardiogenic shock | New ASCVD guidelines ()
Acute Coronary Syndromes: Heart disease still the No. 1 killer | Building accurate AI models for CVD ()
The reason behind inflammation, blood clotting in some COVID patients | 2 FDA approvals for Medtronic ()
The top US hospitals for cardiology & heart surgery | Diabetes & TEER | Improving AI for CVD ()
Economics & Policy: $103M to battle burnout | FDA's statin update | Heartflow to go public | Cardiologist wealth ()
ARBs vs. ACE inhibitors | PCI rates down 10% | Reducing the risk of infection when CIED patients develop hematomas ()
Marijuana use & stroke | Watchman FLX LAAC device safe for nonvalvular AFib | Heart health & pregnancy outcomes ()
Week in Review: HeartFlow to go public | TAVR news from TVT 2021 | FDA wants to update statin warnings ()
Heart disease the No. 1 killer in US | 1-year TAVR outcomes in low-risk bicuspid AS patients | AFib in young adults ()
Heart Failure: Empagliflozin for HFpEF | Catheter ablation a cost-effective treatment option | HF & TEER ()
IVC filter removal device earns FDA's breakthrough designation | PCI for high-risk SCAD patients | $80M in funding ()
FDA pushes for statin warnings to be updated | Cardiologist to pay $2M to settle kickback allegations ()
Structural Heart Disease: 4D holograms | CHD & stroke | HF patients undergoing TEER ()
Coffee & heart rhythm issues | FDA grants breakthrough device designation to AAA sealing system | Wall Street stumbles ()
Imaging & Physiology: 'Right to repair' | Predicting heart rhythm issues in COVID patients | A new 3D MRI technique ()
DOACs outperform VKAs | HeartFlow to merge, go public in deal worth $2.4B | $103M to fight burnout ()
News Alert: HeartFlow announces plans to merge, go public in deal worth $2.4B ()
Week in Review: Athletes & AFib | Healthcare's 'right to repair' moment | Battling burnout | FDA approvals ()
An update on children with COVID-related MIS-C | 3-in-1 device gains FDA approval | Primary care for stroke patients ()
Prevention & Risk Reduction: A key FDA approval | AI model detects diabetes risk | Insulin syringes recalled ()
Athletes more likely to develop AFib | The 'right to repair' debate continues | New spray could help heal body after MI ()
Practice Management: Cardiologists push for change | TAVR & mitral valve interventions during the same visit ()
Just 21% of academic cardiologists are women—and they earn less than men | Cardiologists unite against burnout ()
TAVR: Long-term outcomes | Valve-in-valve TAVR after one year | To delay or not to delay ()
Bayer's big news | Predicting heart issues in COVID-19 patients | Beloved cardiologist dies at 86 ()
Interventional & Surgery: Prasugrel & PCI | A key approval for Medtronic ()
A new MRI technique | Embrace plant-based foods, limit most meats to avoid heart disease ()
Week in Review: Blood tests recalled | TAVR still comparable to surgery after 8 years | Empagliflozin & HFpEF ()
COVID-19: Heart issues can last for months | A big FDA announcement | AI-powered detection ()
TAVR vs. surgery after 8 years | Omega-3 fatty acids | COVID-related heart issues often last for months ()
Empagliflozin for HFpEF | AI predicts diabetes risk | Congenital heart disease & stroke ()
Vascular & Endovascular: Noteworthy recalls | A new way to help stroke survivors ()
Permanent pacemakers & TAVR | Medtronic Vascular recalls 55K angiographic guidewire components ()
FDA announces recall of blood tests due to 'significant concerns' | Cardiologists worth at least $5M ()
Heart Rhythm: AFib & alcohol | New data on sudden cardiac death | ACC, HRS launch new efforts to boost care ()
Week in Review: A strong showing for tirzepatide | 4D holograms | Prasugrel vs. ticagrelor | HCM & AFib ()
Risk score predicts TEER outcomes | Cardiologist completes LAAO with 3D ICE catheter ()